T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis
Circulation Research · 2026
DOI: 10.1161/circresaha.125.328073 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Circulation Research, 2026. Verfasst von Jakub Tomek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Physiology and Genetics (J.T., H.J.), University of Oxford, United Kingdom. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Arrhythmias, Cardiac, Models, Cardiovascular, Computer Simulation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Cardiovascular disease is the leading global cause of morbidity and mortality. New technologies are needed to improve mechanistic understanding and inform therapeutic strategies. Human-centric cardiac simulations show great promise; however, existing cellular models can reproduce only a few arrhythmia-driving behaviors and show important discrepancies with experimental data. We aimed to develop a new model overcoming this lack of generality, which markedly limits the predictivity and translational utility of virtual cardiomyocytes. METHODS: We developed T-World, a novel virtual human cardiomyocyte, using data-driven differential equations to describe sex-specific excitation-contraction coupling, mechanical contraction, β-adrenergic signaling, and its effects on cellular targets. The model contains several key innovations, including a new approach to coupling L-type calcium channels and ryanodine receptors, with updated calcium-dependent-inactivation of the former and novel calcium-induced refractoriness and complete reparameterization of the latter. We also redeveloped the sodium-potassium pump and made major improvements to the sodium-calcium exchanger formulation. RESULTS: T-World shows broad agreement with experimental data on rate-dependent action potential (AP), calcium handling, and contraction properties. Extensively validated on independent data, T-World demonstrates strong predictive performance, for example, in drug-induced AP changes. The model reproduces the effects of sympathetic stimulation, including AP duration shortening and increased calcium-transient amplitude and contractility. Importantly, it recapitulates for the first time all key cellular mechanisms driving life-threatening arrhythmias (early and delayed afterdepolarizations, alternans, and steep S1-S2 restitution), including experimentally observed responses to interventions such as sympathetic activation, SERCA (sarco/endoplasmic reticulum Ca 2+ ATPase) inhibition, and AP prolongation. Combined with the model’s ability to simulate physiological sex-specific differences in electrophysiology, this revealed increased proclivity of female cardiomyocytes to early afterdepolarizations and steep restitution of AP duration. CONCLUSIONS: T-World is a highly general and predictive open-source computer model of a human ventricular cardiomyocyte, suitable for multiscale research studies investigating determinants of arrhythmogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Physiology and Genetics (J.T., H.J.), University of Oxford, United Kingdom.
- Department of Pharmacology, University of California, Davis (J.T., D.M.B.).
- Department of Computer Science (M.H., A.B., A.B.-O., B.R.), University of Oxford, United Kingdom.
- Department of Physiology, McGill University, Montreal, CA (T.B.).
- Ludwig Cancer Research (M.T.), University of Oxford, United Kingdom.
- Department of Pharmacology and Pharmacotherapy, University of Szeged, Hungary (N.N.).
ORCID-Profile: Jakub Tomek, Marketa Tomkova, Heeseung Jo, Norbert Nagy, Ambre Bertrand, Alfonso Bueno-Orovio, Michael A Colman, Blanca Rodriguez, Donald M Bers, Jordi Heijman
Förderung
- Wellcome Trust
- Medical Research Council
- NHLBI NIH HHS
Zitieren
APA
Tomek, J., Holmes, M., Bury, T., Tomkova, M., Jo, H., Nagy, N., Bertrand, A., Bueno-Orovio, A., Colman, M. A., Rodriguez, B., Bers, D. M., & Heijman, J. (2026). T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis. Circulation Research. https://doi.org/10.1161/circresaha.125.328073
Vancouver
Tomek J, Holmes M, Bury T, Tomkova M, Jo H, Nagy N, et al. T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis. Circulation Research. 2026. doi:10.1161/circresaha.125.328073
BibTeX
@article{Tomek2026,
author = {Tomek, Jakub and Holmes, Maxx and Bury, Thomas and Tomkova, Marketa and Jo, Heeseung and Nagy, Norbert and Bertrand, Ambre and Bueno-Orovio, Alfonso and Colman, Michael A and Rodriguez, Blanca and Bers, Donald M and Heijman, Jordi},
title = {T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis},
journal = {Circulation Research},
year = {2026},
doi = {10.1161/circresaha.125.328073}
}
EUVIMED